Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Colonic Diseases
>>
Merck (MSD)
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Koselugo
(selumetinib) / Merck (MSD), AstraZeneca
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Zolinza
(vorinostat) / Merck (MSD)
dalotuzumab
(MK 0646) / Merck (MSD), Pierre Fabre
MK-2206
/ Merck (MSD)
Lynparza
(olaparib) / Merck (MSD), AstraZeneca
robatumumab
(SCH 717454) / Merck (MSD)
